Dr Angwin is a leading researcher in language neuroscience with a PhD from the University of Queensland and is an Associate Professor at a leading University in Australia. Anthony has expertise in the use of neuroimaging and computerised tests of cognitive-linguistic function to examine language processing, with a particular focus on language impairments in people with neurogenic communication disorders, including dementia and Parkinson’s disease. Anthony joins Redenlab as a science lead for language outcomes in clinical trials.